A Single-dose Cross-over Study to Assess Direct and Indirect Effects of Dapagliflozin on Pancreatic Alpha and Beta Cells in Patients With Type 2 Diabetes

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2016
The purpose of this study is to evaluate if Dapagliflozin has direct effect on alpha cell glucagon release.
Epistemonikos ID: c12ff0cca294634db467c4764f7bbbd3ef76046e
First added on: May 13, 2024